- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: capecitabine [Xeloda]
Total 1991 results
-
Wuhan UniversityCompletedMalignant Neoplasm of StomachChina
-
Novartis PharmaceuticalsTerminatedCancerCzechia, Poland, Russian Federation, United Kingdom, Israel
-
SanofiRegeneron PharmaceuticalsWithdrawn
-
UNICANCERCompleted
-
NSABP Foundation IncNational Cancer Institute (NCI)UnknownBreast CancerUnited States, Canada, Puerto Rico
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
Qilu Pharmaceutical Co., Ltd.Recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Unresectable Pancreatic Neuroendocrine CarcinomaUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
AstraZenecaDaiichi SankyoRecruitingGastric Cancer | Colorectal Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Cancer | Biliary Tract Cancer | Metastatic Castration-resistant Prostate CancerSpain, China, Korea, Republic of, Canada, Italy, Poland, Turkey, United Kingdom, Japan, Taiwan, United States, France, Germany, Switzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyTerminatedPancreatic Adenocarcinoma | Stage III Pancreatic CancerUnited States
-
The Fourth Affiliated Hospital of Zhejiang University...Second Affiliated Hospital, School of Medicine, Zhejiang UniversityRecruiting
-
Anhui Provincial HospitalNot yet recruiting
-
Eli Lilly and CompanyARMO BioSciencesActive, not recruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Carcinoma | Solid Tumors | Colorectal Carcinoma | Pancreatic CarcinomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnMerkel Cell Carcinoma | Neuroendocrine Neoplasm | Metastatic Carcinoid Tumor | Functional Pancreatic Neuroendocrine Tumor | Malignant Somatostatinoma | Metastatic Adrenal Gland Pheochromocytoma | Multiple Endocrine Neoplasia Type 1 | Multiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia... and other conditions
-
Tianjin Medical University Cancer Institute and...UnknownChemotherapy Effect | Susceptibility, GeneticChina
-
German Breast GroupCompleted
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
University of CincinnatiRecruitingAnal CancerUnited States
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Canada, France, Italy, Spain, United Kingdom, Hungary, Poland, United States, Korea, Republic of, Brazil, India, Japan, Russian Federation, China, Taiwan, Netherlands, Germany, South Africa, Argentina
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA); Baltimore City Health DepartmentEnrolling by invitationOpioid-use DisorderUnited States
-
University of Texas Southwestern Medical CenterWithdrawnStage II Rectal Cancer | Stage III Rectal CancerUnited States
-
PD Dr. med. Volker HeinemannRoche Pharma AGUnknown
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced Rectal CancerUnited States, Spain
-
Herbert Hurwitz, MDNational Cancer Institute (NCI)Completed
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Fujian Cancer HospitalNot yet recruitingMetastatic Nasopharyngeal Carcinoma | Intermittent Systematic Chemotherapy
-
Qilu Pharmaceutical Co., Ltd.Not yet recruiting
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....Not yet recruiting
-
Ono Pharmaceutical Co. LtdBristol-Myers SquibbCompletedGastric CancerChina, Japan, Korea, Republic of, Taiwan
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Sierra Oncology, Inc.TerminatedRelapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
SanofiRegeneron PharmaceuticalsTerminated
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundCompletedPancreatic CancerUnited Kingdom
-
Tang-Du HospitalRecruiting
-
Lund University HospitalDanish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast NeoplasmsDenmark, Sweden
-
Hoffmann-La RocheCompletedColorectal CancerItaly, Korea, Republic of, United Kingdom, Belgium, Argentina, Denmark, Greece, Netherlands, Slovenia, Spain, Sweden, Turkey, Brazil, Bosnia and Herzegovina, France, Germany, Portugal, Egypt, Poland, Slovakia, Mexico, Serbia, Russian...
-
Tyme, IncCompletedPancreatic CancerUnited States
-
University of Southern CaliforniaCTI BioPharmaWithdrawnBreast CancerUnited States
-
Auxilio Mutuo Cancer CenterUnknownInfiltrating Duct and Lobular Carcinoma In Situ | Invasive Lobular Breast Carcinoma | Inflammatory Breast CarcinomaPuerto Rico
-
University of PittsburghGenentech, Inc.Completed
-
German Breast GroupCompleted
-
Suzhou Transcenta Therapeutics Co., Ltd.Bristol-Myers SquibbRecruiting
-
Federation Francophone de Cancerologie DigestiveRecruitingColorectal Cancer Metastatic | Microsatellite Stable | High Immune InfiltrateFrance
-
Pierre Fabre MedicamentCompleted